vs
Side-by-side financial comparison of Hilltop Holdings Inc. (HTH) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $164.7M, roughly 1.8× PTC THERAPEUTICS, INC.). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs -82.0%, a 94.9% gap on every dollar of revenue. Over the past eight quarters, Hilltop Holdings Inc.'s revenue compounded faster (0.6% CAGR vs -11.5%).
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
HTH vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $300.5M | $164.7M |
| Net Profit | $39.0M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | 13.0% | -82.0% |
| Revenue YoY | — | -22.7% |
| Net Profit YoY | -12.4% | -104.8% |
| EPS (diluted) | $0.64 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $300.5M | — | ||
| Q4 25 | $329.9M | $164.7M | ||
| Q3 25 | $330.2M | $211.0M | ||
| Q2 25 | $303.3M | $178.9M | ||
| Q1 25 | $318.5M | $1.2B | ||
| Q4 24 | $301.1M | $213.2M | ||
| Q3 24 | $305.5M | $196.8M | ||
| Q2 24 | $297.0M | $186.7M |
| Q1 26 | $39.0M | — | ||
| Q4 25 | $41.6M | $-135.0M | ||
| Q3 25 | $45.8M | $15.9M | ||
| Q2 25 | $36.1M | $-64.8M | ||
| Q1 25 | $42.1M | $866.6M | ||
| Q4 24 | $35.5M | $-65.9M | ||
| Q3 24 | $29.7M | $-106.7M | ||
| Q2 24 | $20.3M | $-99.2M |
| Q1 26 | — | — | ||
| Q4 25 | 16.1% | -43.3% | ||
| Q3 25 | 18.4% | 1.4% | ||
| Q2 25 | 16.3% | -19.5% | ||
| Q1 25 | 18.1% | 82.5% | ||
| Q4 24 | 14.7% | -76.2% | ||
| Q3 24 | 13.9% | -27.7% | ||
| Q2 24 | 10.0% | -21.5% |
| Q1 26 | 13.0% | — | ||
| Q4 25 | 12.6% | -82.0% | ||
| Q3 25 | 13.9% | 7.5% | ||
| Q2 25 | 11.9% | -36.3% | ||
| Q1 25 | 13.2% | 73.7% | ||
| Q4 24 | 11.8% | -30.9% | ||
| Q3 24 | 9.7% | -54.2% | ||
| Q2 24 | 6.8% | -53.1% |
| Q1 26 | $0.64 | — | ||
| Q4 25 | $0.68 | $-1.63 | ||
| Q3 25 | $0.74 | $0.20 | ||
| Q2 25 | $0.57 | $-0.83 | ||
| Q1 25 | $0.65 | $10.04 | ||
| Q4 24 | $0.55 | $-0.85 | ||
| Q3 24 | $0.46 | $-1.39 | ||
| Q2 24 | $0.31 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | $990.8M | — |
| Stockholders' EquityBook value | $2.2B | $-205.3M |
| Total Assets | $15.7B | $2.9B |
| Debt / EquityLower = less leverage | 0.46× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.1B |
| Q1 26 | $990.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $-205.3M | ||
| Q3 25 | $2.2B | $-155.8M | ||
| Q2 25 | $2.2B | $-206.5M | ||
| Q1 25 | $2.2B | $-185.8M | ||
| Q4 24 | $2.2B | $-1.1B | ||
| Q3 24 | $2.2B | $-1.1B | ||
| Q2 24 | $2.1B | $-980.2M |
| Q1 26 | $15.7B | — | ||
| Q4 25 | $15.8B | $2.9B | ||
| Q3 25 | $15.6B | $2.6B | ||
| Q2 25 | $15.4B | $2.6B | ||
| Q1 25 | $15.8B | $2.7B | ||
| Q4 24 | $16.3B | $1.7B | ||
| Q3 24 | $15.9B | $1.8B | ||
| Q2 24 | $15.6B | $1.9B |
| Q1 26 | 0.46× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-38.7M | $-34.3M | ||
| Q3 25 | $273.0M | $-66.3M | ||
| Q2 25 | $-234.6M | $-58.3M | ||
| Q1 25 | $5.8M | $870.1M | ||
| Q4 24 | $273.9M | $-30.0M | ||
| Q3 24 | $515.6M | $-77.0M | ||
| Q2 24 | $-435.3M | $-71.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-55.5M | $-36.6M | ||
| Q3 25 | $271.0M | $-69.7M | ||
| Q2 25 | $-234.6M | $-59.6M | ||
| Q1 25 | $5.0M | $868.4M | ||
| Q4 24 | $266.8M | $-33.8M | ||
| Q3 24 | $513.8M | $-77.5M | ||
| Q2 24 | $-437.3M | $-78.8M |
| Q1 26 | — | — | ||
| Q4 25 | -16.8% | -22.3% | ||
| Q3 25 | 82.1% | -33.1% | ||
| Q2 25 | -77.4% | -33.3% | ||
| Q1 25 | 1.6% | 73.8% | ||
| Q4 24 | 88.6% | -15.8% | ||
| Q3 24 | 168.2% | -39.4% | ||
| Q2 24 | -147.2% | -42.2% |
| Q1 26 | — | — | ||
| Q4 25 | 5.1% | 1.4% | ||
| Q3 25 | 0.6% | 1.6% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 2.4% | 1.8% | ||
| Q3 24 | 0.6% | 0.3% | ||
| Q2 24 | 0.7% | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | -0.93× | — | ||
| Q3 25 | 5.96× | -4.17× | ||
| Q2 25 | -6.50× | — | ||
| Q1 25 | 0.14× | 1.00× | ||
| Q4 24 | 7.71× | — | ||
| Q3 24 | 17.36× | — | ||
| Q2 24 | -21.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
PTCT
Segment breakdown not available.
